Identification of a novel and myeloid specific role of the leukemia-associated fusion protein DEK-NUP214 leading to increased protein synthesis

Genes, Chromosomes & Cancer
Malin AgebergAnders Lindmark

Abstract

The t(6;9)(p22;q34) chromosomal translocation is found in a subset of patients with acute myeloid leukemia (AML). The translocation results in a fusion between the nuclear phosphoprotein DEK and the nucleoporin NUP214 (previously CAN). The mechanism by which the fusion protein DEK-NUP214 contributes to leukemia development has not been identified, and disruptions of normal cellular functions by DEK-NUP214 have previously not been described. In the present study, a novel effect of the DEK-NUP214 fusion protein is demonstrated. Our findings reveal a substantial increase in global protein synthesis in DEK-NUP214 expressing cells. Furthermore, we conclude that this effect is not the result of dysregulated transcription but merely due to increased translation. Consistent with the association with AML, the increased protein synthesis mediated by DEK-NUP214 is restricted to cells of the myeloid lineage. Analysis of potential mechanisms for regulating protein synthesis shows that expression of DEK-NUP214 correlates to the phosphorylation of the translation initiation protein, EIF4E. The present data provide evidence that increase of translational activity constitutes a mechanism by which the leukemogenic effect of DEK-NUP124 may be med...Continue Reading

References

May 15, 1976·International Journal of Cancer. Journal International Du Cancer·C Sundström, K Nilsson
Oct 1, 1992·Baillière's Clinical Haematology·M von LindernG Grosveld
Jan 1, 1992·Current Topics in Cellular Regulation·C G Proud
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·G K FuD M Markovitz
Jul 8, 1998·European Journal of Biochemistry·M KleijnA A Thomas
Sep 1, 2000·Seminars in Cell & Developmental Biology·L González-MariscalA Avila-Flores
Nov 4, 2000·International Journal of Cancer. Journal International Du Cancer·C GrottkeH Lage
Apr 5, 2002·The Journal of Gene Medicine·Thomas RelanderJohan Richter
Oct 17, 2003·The Journal of Biological Chemistry·Ghada GhannamNabeel R Yaseen
Nov 19, 2003·Biochemical and Biophysical Research Communications·Andreas LennartssonUrban Gullberg
Nov 25, 2003·Nucleic Acids Research·Tanja WaldmannClaudia Gruss
Jan 24, 2004·Leukemia & Lymphoma·Sílvia CasasSakari Knuutila
Mar 23, 2004·Annual Review of Immunology·Stephane Wong, Owen N Witte
Apr 20, 2004·Oncogene·Yaël MamaneNahum Sonenberg
Apr 20, 2004·Oncogene·Vinagolu K Rajasekhar, Eric C Holland
May 25, 2004·Oncogene·Luke F Peterson, Dong-Er Zhang
Jun 17, 2004·Molecular and Cellular Biology·Ferdinand KappesTanja Waldmann
Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ming YanDong-Er Zhang
May 24, 2005·Experimental Cell Research·Emelie SvenssonUrban Gullberg
Jan 18, 2006·Stem Cells·Bertrand W ParcellsKathleen M Sakamoto
May 25, 2006·Cell Cycle·Maria Stella CarroHeiko Müller
Aug 9, 2006·Molecular and Cellular Biology·Trisha M Wise-DraperSusanne I Wells

❮ Previous
Next ❯

Citations

May 27, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erica Riveiro-Falkenbach, María S Soengas
Nov 18, 2010·Expert Review of Molecular Diagnostics·Christopher D Watt, Adam Bagg
Apr 19, 2011·Expert Review of Hematology·Wan-Jen Hong, Bruno C Medeiros
Mar 15, 2015·Leukemia·C Sandén, U Gullberg
Aug 17, 2014·Blood Cells, Molecules & Diseases·Gemma E LoganMelanie J Percy
Jul 31, 2009·Science in China. Series C, Life Sciences·Ying HuaXiangLei Peng
Jul 7, 2009·Seminars in Cell & Developmental Biology·Songli Xu, Maureen A Powers
Jul 7, 2012·Journal of Cutaneous Pathology·Rajiv M PatelLinglei Ma
Apr 14, 2016·European Journal of Human Genetics : EJHG·Valeria NofriniCristina Mecucci
Sep 12, 2018·European Journal of Haematology·Sabine Kayser, Mark J Levis
Mar 12, 2008·Molecular and Cellular Biology·F KappesE Ferrando-May
Jan 24, 2019·Cells·Adélia Mendes, Birthe Fahrenkrog
Feb 10, 2021·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Hong FangShimin Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.